Evaluation of lymphocytic responses after treatment with bacillus Calmette-Guerin and interferon-α 2b for superficial bladder cancer

Clinical Immunology

Volumn 90, Issue 2, 1999, Pages 230-237

  Gan, Yunn Hwen ^a   Mahendran, Ratha ^a   James, Keith ^b   Lawrencia, Carmel ^a   Esuvaranathan, Kesavan ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Bacillus Calmette Guerin; Bladder cancer; Interferon alpha; T lymphocyte

Indexed keywords

ALPHA2B INTERFERON; BCG VACCINE; CYTOKINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HELPER CELL; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; LYMPHOCYTE COUNT; LYMPHOKINE ACTIVATED KILLER CELL; PRIORITY JOURNAL; SUPERFICIAL CANCER;

EID: 0032957643     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1998.4647     Document Type: Article

References (27)

1. Morales, A., Eidinger, D., and Bruce, A. W., Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J. Urol. 16, 180-183, 1976.
2. Brosman, S. A., Bacillus Calmette-Guerin immunotherapy: Techniques and results. Urol. Clin. North Amer. 19, 557-564, 1992.
3. Lamm, D. L., Complications of bacillus Calmette-Guerin immunotherapy. Urol. Clin. North Amer. 19, 565-572, 1992.
4. Glashan, R. W., A randomized controlled study of intravesical α-2b-interferon in carcinoma in situ of the bladder. J. Urol. 144, 658-661, 1990.
5. Torti, F. M., Shortliffe, R. D., Williams, R. D., Pitts, W. C., Kempson, R. L., Ross, J. C., Palmer, J., Meyers, F., Ferrari, M., Hannigan, J., Spiegel, R., McWhirter, K., and Freiha, F., Alpha-interferon in superficial bladder cancer: A Northern California Oncology Group study. J. Clin. Oncol. 6, 476-483, 1988.
6. Sargent, E. R., and Williams, R. D., Immunotherapeutic alternatives in superficial bladder cancer: Interferon, interleukin-2 and keyhole-limpet hemocyanin. Urol. Clin. North Amer. 19, 581-589, 1992.
7. Mitzutani, Y., Nio, Y., Fukumoto, M., and Yoshida, O., Effects of bacillus Calmette-Guerin on cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly isolated autologous urinary bladder transitional carcinoma cells in patients with urinary bladder cancer. Cancer 69, 537-545, 1992.
8. Ratliff, T. L., Gillen, D., and Catalona, W. J., Requirement of a thymus dependent immune response for BCG-mediated antitumor activity. J. Urol. 137, 155-158, 1987.
9. Ratliff, T. L., Ritchey, J. K., Yuan, J. J. J., Andriole, G. L., and Catalona, W. J., T-cell subsets required for intravesical BCG immunotherapy for bladder cancer. J. Urol. 150, 1018-1023, 1993.
10. Bruno, S., Machi, A. M., Semino, C., Meta, M., Ponte, M., Varaldo, M., Curotto, A., Ferlazzo, G., Decensi, A., and Melioli, G., Phenotypic, functional and molecular analysis of lymphocytes associated with bladder cancer. Cancer Immunol. Immunother. 42, 47-54, 1996.
11. Lozzio, C. B., and Lozzio, B. B., Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45, 321-338, 1975.
12. Coligan, J. E., Kruisbeek, A. M., Margulies, D. H., Shevach, E. M., and Strober, W. (Eds), "Current Protocols in Immunology," pp. 7.18.1-7, Wiley, New York, 1992.
13. De Boer, E. C., De Jong, W. H., Van Der Meijden, A. P., Steerenberg, P. A., Witjes, J. A., Vegt, P. D., Debruyne, F. M., and Ruitenberg, E. J., Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guerin. Cancer Immunol. Immunother. 33, 411-416, 1991.
14. Bohle, A., Gerdes, J., Ulmer, A. J., Hofstetter, A. G., and Flad, H. D., Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall. J. Urol. 144, 53-58, 1990.
15. Prescott, S., James, K., Hargreave, T. B., Chisholm, G. D., and Smyth, J. F., Intravesical Evans strain BCG therapy: Quantitative immunohistochemical analysis of the immune response within the bladder wall. J. Urol. 147, 1636-1642, 1992.
16. El-demiry, M. I. M., Hargreave, T. B., Busuttil, A., James, K., and Chisholm, G. D., Immunohistochemical identification of lymphocyte subsets and macrophages in normal human urothelium using monoclonal antibodies. Br. J. Urol. 58, 436-442, 1986.
17. Inoue, T., Yoshikai, Y., Matsuzaki, G., and Nomoto, K., Early appearing γδ-bearing T cells during infection with Calmette-Guerin bacillus. J. Immunol. 146, 2754-2762, 1991.
18. Alexandroff, A. B., Black, J. M., Bollina, P. R., and James, K., Differential production of γδ T cells in the urine of bladder cancer patients receiving bacillus Calmette guerin immunotherapy. Int. J. Oncol. 10, 387-393, 1997.
19. Kabelitz, D., Function and specificity of human γ/δ-positive T cells. Crit. Rev. Immunol. 11, 281-303, 1992.
20. Mack, D., Gomahr, A., Herold, M., Aulitzky, W., and Frick, J., Immune parameters of patients treated with low dose BCG in superficial cancer. Oncology 3, 261-275, 1994.
21. Jackson, A. M., Alexandroff, A. B., Kelly, R. W., Skibinska, A., Esuvaranathan, K., Prescott, S., Chisholm, G. D., and James, K., Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after Bacillus Calmette-Guerin immunotherapy. Clin. Exp. Immunol. 99, 369-375, 1995.
22. Fleishmann, J. D., Toossi, Z., Ellner, J. J., Wentworth, D. B., Ratliff, T. L., and Imbembo, A. L., Urinary interleukins in patients receiving intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer. Cancer 64, 1447-1454, 1989.
23. Pollock, R. E., and Roth, J. A., Cancer-induced immunosuppression: Implications for therapy. Semin. Surg. Oncol. 5, 414-419, 1989.
24. Pross, H. F., and Lotzova, E., Role of natural killer cells in cancer. Nat. Immun. 12, 279-292, 1993.
25. Ioannides, C. G., and Whiteside, T. L., T cell recognition of human tumors: implications for molecular immunotherapy of cancer. Clin. Immunol. Immunopathol. 66, 91-106, 1993.
26. van der Meijden, A. P. M., Steerenberg, P. A., van Hoogstraaten, M. W., Kerckhaert, Ja. A., Schreinemachers, L. M. H., Harthoorn-Lasthuizen, E. J., Hagenaars, A. M., de Jong, W. H., Debruijne, F. M. J., and Ruitenberg, E. J., Immune reactions in patients with superficial bladder cancer after intradermal and intravesical treatment with bacillus Calmette-Guerin. Cancer Immunol. Immunother. 28, 287-295, 1989.
27. Carballido, J. A., Molto, L. M., Manzano, L., Olivier, C., Salmeron, J., and Alvarez de Mon, M., Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder. Cancer 72, 1743-1748, 1993.